Moderna Dropped by 20% This Week -- Is It a Smart Buy Right Now?
The main reason for this week's decline is that Moderna lowered its 2025 full-year revenue guidance, and by a wide margin.
Hosted on MSN2h
How to Play Moderna Stock After the Recent Sales Guidance Cut
Moderna MRNA provided an update on its financial outlook and pipeline progress at the J.P. Morgan Healthcare Conference. At ...
CDC upgrades its advisory on bird flu. Will Moderna’s stock get a boost?
CDC officials say medical professionals are seeing more patients whose illness cannot be traced back to an infected animal or ...
7 Inspiring Exhibitions To See In Bilbao, Florence, Lisbon, London And Sintra
Dame Tracey Emin and Sir Grayson Perry are celebrated with solo exhibitions at the suitably palatial Palazzo Strozzi in ...
Northeast Ohio pediatrician’s office working with Moderna on a potential mono vaccine
The research team at Senders Pediatrics is working with Moderna to study a vaccine developed for Epstein-Barr Virus, which causes mono.
US announces new funds for mRNA vaccines, fast tracks bird flu tests
Companies including Moderna and Pfizer are working on mRNA vaccines for bird flu. Read more at straitstimes.com.
MM&M22h
Rx Rundown: Johnson & Johnson, Eli Lilly, the FDA and more
N-Power Medicine, backed by Merck GHI, announced the acquisition of Syapse Holdings. Samsung Biologics and LigaChem extended their ADC services deal. Publicis Worldwide merged with Leo Burnett to form ...
Hosted on MSN13h
Arbutus Biopharma Sets Sights on Advancing HBV Cure in 2025
Arbutus Biopharma Corporation (NASDAQ: ABUS) has unveiled its strategic objectives for 2025 alongside an encouraging ...